Document is current
Any future updates will be listed below
-
Authors
Tölle, Malte https://orcid.org/0000-0002-0804-5794
Garthe, Philipp
Scherer, Clemens https://orcid.org/0000-0003-2816-6793
Seliger, Jan Moritz
Leha, Andreas https://orcid.org/0000-0002-8072-1988
Krüger, Nina
Simm, Stefan https://orcid.org/0000-0001-9371-2709
Martin, Simon
Eble, Sebastian
Kelm, Halvar
Bednorz, Moritz https://orcid.org/0000-0002-4981-5732
André, Florian
Bannas, Peter https://orcid.org/0000-0002-7102-534X
Diller, Gerhard
Frey, Norbert
Groß, Stefan https://orcid.org/0000-0003-4121-7161
Hennemuth, Anja https://orcid.org/0000-0002-0737-7375
Kaderali, Lars https://orcid.org/0000-0002-2359-2294
Meyer, Alexander
Nagel, Eike
Orwat, Stefan
Seiffert, Moritz
Friede, Tim https://orcid.org/0000-0001-5347-7441
Seidler, Tim
Engelhardt, Sandy
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 2 January 2025
First Online: 6 February 2025
Competing interests
: NF reports speaker honoraria, presentations or advisory board consultations from AstraZeneca, Bayer AG, Boehringer Ingelheim, Novartis, Pfizer, Daiichi Sankyo Deutschland. TS reports research, educational, or travel grants and honoraria for lectures or advisory board consultations from Abbott Vascular, AstraZeneca, BoehringerIngelheim, Bristol Myers Squibb, Corvia, Cytokinetics, Edwards Life Sciences, Medtronic, Myocardia, Novartis, Pfizer, Teleflex. AM reports consulting or lecturing fees from Medtronic, Bayer, Pfizer. CS reports speaker honorarium from AstraZeneca. SE reports speaker honorarium from Boehringer Ingelheim. None are related to the content of the manuscript. The authors declare no conflicts of interest.
